// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Identifying risk factors for severity & activity of Graves Orbitopathy – a multi‐centre analysis of the characteristics and treatment of patients with Thyroid Eye Disease

Soma Farag - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congenital hyperthyroidism

Selenium

The ability of eye tracking perimetry to detect glaucoma

Andrew Tatham - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

In Vivo anterior Optic Nerve Head changes as a function of Visual Field loss in Glaucoma

Ryan Lee Bartlett - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Outcomes and risk factor for failure after Aqueous Shunt Implants – annual review of one service results and benchmark

Renata Puertas - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Benchmarking posterior capsule rupture rate in glaucoma patients before and after patient‐surgeon risk match

Fernanda Susanna - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Prevalence of Endophthalmitis after Aqueous Shunt Implants and related procedures in an eye service

Renata Puertas - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The relationship between ambient air pollution and glaucoma phenotypes in a large community cohort

Sharon Chua - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

The role and mechanism of retinal ganglion cell death in glaucomatous injury

Zara Ali - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Afro‐Caribbean patients have a lower disc vascular density than European patients: a cross‐sectional study

Maria Liseth Salazar Qui�ones - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Curry to treat Alzheimer’s disease?

Ehtesham Shamsher - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

An unusual case of intradural haemangioma of the optic nerve mimicking optic neuritis

Abigail Hopkins - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Solo surgeon strabismus surgery technique

Phey Feng Lo - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The grading of risk factors for diabetes based on early loss of colour and flicker sensitivity

Qais Bastaki - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Comparison of peak times of photopic flicker electroretinogram responses recorded using conventional and portable systems in Birdshot chorioretinopathy

Aleksandra Pekacka - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Harnessing the power of OCT imaging in clinic by smart data analysis and presentation

Timothy Yap - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Objective assessment of progressive macular changes in glaucoma

Eduardo M. Normando - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Detecting structural progression

Andrew Tatham - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Colour assessment in patients at risk of developing diabetes

Marisa Rodriguez-Carmona - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic retinopathy

N/A

Abnormalities of vision and colour vision in Parkinson's disease

Rimona Weil - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Assessing loss of colour vision in patients with clinical disorders

John L. Barbur - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Age-Related Macular Degeneration

N/A

Copyright © 2026. QuantiNova All rights reserved